Engineering approaches, including microfluidics, bioprinting, and genetic engineering, have transformed the capacity to model tissue morphogenesis in vitro. These platforms enable precise programming of biophysical and chemical cues that influence collective cell behaviors, creating experimental systems for studying how cells integrate microenvironmental signals to drive developmental processes. This review examines engineered approaches for creating morphogenetic models and evaluates their complementary capabilities, constraints, and potential for integration. Microfluidic devices are discussed for generating stable biochemical gradients and controlling fluid dynamics in two-dimensional and three-dimensional configurations. Extrusion and digital light-processing (DLP) bioprinting enable the construction of spatially organized three-dimensional cellular assemblies with platform-specific trade-offs between resolution, viability, and scalability. Optogenetic systems provide spatiotemporal control over gene expression for patterning morphogenic events. The review systematically addresses technical and biological constraints, including gradient instability, resolution-viability trade-offs, phototoxicity, and the persistent gap between morphological patterning and functional maturation. We conclude with guidance for platform selection and a discussion of how integrating these complementary technologies may accelerate mechanistic understanding of morphogenesis.
Burmas et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: